View More Recent Stories

Sep 25, 2023 07:00AM BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
Sep 19, 2023 02:00AM Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western™ Platform
Aug 14, 2023 07:00AM BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
May 18, 2023 07:00AM EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
May 16, 2023 07:00AM BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
May 10, 2023 07:00AM BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
Apr 17, 2023 07:10AM Bio-Techne (TECH) And Lunaphore Establish Strategic Partnership To Develop The First Fully Automated Same-slide Spatial Multiomics Solution
Apr 17, 2023 07:00AM BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
Apr 13, 2023 07:00AM BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE
Apr 5, 2023 07:00AM BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA™ INSTRUMENTS NOW IN OPERATION
Jun 24, 2021 07:00AM Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR‑NK Cell Manufacturing Technologies
Jun 24, 2021 07:00AM Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
Jun 2, 2021 11:34AM Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order
May 4, 2021 02:20PM Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards
Mar 10, 2021 10:31AM Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category
Feb 10, 2021 11:33AM FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma (RNLX)
Feb 10, 2021 11:31AM FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma
Feb 8, 2021 07:30AM Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
Nov 25, 2020 07:31AM Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies (RNLX)
Nov 25, 2020 07:30AM Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
Oct 28, 2020 07:30AM EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe
Oct 26, 2020 07:35AM CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex Quantitative Antibody Test Kits (RENX) (TECH)
Oct 26, 2020 07:30AM CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex Quantitative Antibody Test Kits
Aug 3, 2020 07:07AM Bio-Techne (TECH) And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
Aug 3, 2020 07:00AM Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
May 19, 2020 04:06PM Bio-Techne (TECH), Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test
May 19, 2020 04:05PM Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test
View More Recent Stories